Neurogene

NGNENasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$682.242 M

$35.69 +0.25%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$90.4M

Loss-making

Shares outstanding

15,574,293

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#189Phathom PharmaceuticalsPHAT$691.7M
#190Zevra TherapeuticsZVRA$686.5M
#191NeurogeneNGNE$682.2M
#192Immix BiopharmaIMMX$678.4M
#193Faeth TherapeuticsFTH$630.2M

Where these numbers come from

Share counts and financials for Neurogene are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.